VISEN Pharmaceuticals (HKG:2561)
Hong Kong · Delayed Price · Currency is HKD 19.26
-0.29 (-1.48%)
Jul 31, 2026, 4:08 PM HKT
VISEN Pharmaceuticals Market Cap
VISEN Pharmaceuticals has a market cap or net worth of 2.1 billion as of July 31, 2026. Its market cap has decreased by -61.20% in one year.
Market Cap
2.10B
Enterprise Value
1.59B
Revenue
151.34K
Ranking
n/a
PE Ratio
n/a
Stock Price
19.26
ChartMarket Cap Chart
Since March 21, 2025, VISEN Pharmaceuticals's market cap has decreased from 7.20B to 2.10B, a decrease of -70.81%. That is a compound annual growth rate of -59.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 2.10B | -39.04% |
| Dec 31, 2025 | 3.44B | -52.13% |
| Mar 21, 2025 | 7.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Tong Ren Tang Chinese Medicine Company | 5.78B |
| Xuanzhu Biopharmaceutical | 5.69B |
| Edding Genor Group Holdings | 3.30B |
| Golden Throat Holdings Group Company | 2.35B |
| Hua Medicine (Shanghai) | 2.32B |
| CPBIO Holding Company | 2.27B |
| Jacobson Pharma Corporation | 2.14B |
| JBM (Healthcare) | 1.57B |